📰 4 sources covering this story

STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more

First covered 23 hrs ago · latest take 2 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
STAT News
STAT News2 hrs ago
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping a three-decade effort
Le Monde
Le Monde23 hrs ago
France recalls rare disease drug Tavneos after deaths in Japan
France's medicine safety agency announced Wednesday the drug, which is used to treat rare autoimmune diseases, would be withdrawn after it was linked to a series of death in Japan.
France recalls rare disease drug Tavneos after deaths in Japan
France's medicine safety agency announced Wednesday the drug, which is used to treat rare autoimmune diseases, would be withdrawn after it was linked to a series of death in Japan.
The Local France
The Local France🏁 first to report23 hrs ago
France recalls rare disease drug Tavneos after deaths
A drug called Tavneos used to treat rare autoimmune diseases will be pulled from the shelves in France, the country's medicine watchdog said Wednesday, after it was linked to 20 deaths in Japan.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →